Piper Jaffray Raises Price Target on Atricure, Inc. (ATRC) to $30 Following 2Q Results
Piper Jaffray reiterated an Overweight rating on AtriCure Inc. (NASDAQ: ATRC), and raised the price target to $30.00 (from $23.00) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
